A stochastic framework for evaluating CAR T cell therapy efficacy and variability

DOI10.1016/J.MBS.2024.109141zbMATH Open1539.92065MaRDI QIDQ6539718FDOQ6539718

Authors: Chau Hoang, Tuan Anh Phan, Cameron J. Turtle, Jianjun Paul Tian 

Publication date: 15 May 2024

Published in: Mathematical Biosciences (Search for Journal in Brave)

Recommendations

• Parameter estimation and treatment optimization in a stochastic model for immunotherapy of cancer
• Modeling CAR T-cell therapy with patient preconditioning
• A stochastic model for the growth of cancer tumors
• Basic stochastic model for tumor virotherapy
• Numerical simulation of a stochastic model for cancerous cells submitted to chemotherapy

zbMATH Keywords

stopping timestochastic modelingergodic distributionCAR-T cell therapy

Mathematics Subject Classification ID

Medical applications (general) (92C50) Applications of stochastic analysis (to PDEs, etc.) (60H30)

Cites Work

• Title not available (Why is that?)
• Title not available (Why is that?)
• Dynamics of cholera epidemic models in fluctuating environments
• Mathematical model of chimeric anti-gene receptor (CAR) T cell therapy with presence of cytokine
• Data-driven analysis of a mechanistic model of CAR T cell signaling predicts effects of cell-to-cell heterogeneity
• Deterministic and stochastic modeling for PDGF-driven gliomas reveals a classification of gliomas
• Stochastic modeling of tumor progression and immune evasion
• Basic stochastic model for tumor virotherapy

Cited In (1)

• Mathematical model for IL-2-based cancer immunotherapy

This page was built for publication: A stochastic framework for evaluating CAR T cell therapy efficacy and variability

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6539718)